Category: General

General

General

Study Shows ACA Increases Use of Rx Drugs, Decreases Out-of-pocket Spending

Study Shows ACA Increases Use of Rx Drugs, Decreases Out-of-pocket Spending

Aug. 19, 2016 – The Affordable Care Act (ACA) has resulted in increases in the use of prescription drugs and decreases in out-of-pocket spending, according to the RAND Corporation, which conducted a study of how expanded insurance coverage has affected populations that are at risk for high health spending.  Health Affairs, which described the results […]

Read more

General

Gender and Healthcare Communications

Gender and Healthcare Communications

By Nick Colucci, Publicis Health CEO July 21, 2016 — I was moved by a recent op-ed in The New York Times written by former hedge fund trader and CEO of Everytable Sam Polk, which shed harsh light on how the persistence of “bro” talk continues to isolate and keep down women working in Wall […]

Read more

Coalition Rising Leaders Conference: Industry Advocacy Will Help Shape Healthcare’s Political Landscape

May 17, 2016 — Healthcare policy improvements are underway in Washington, and industry advocacy makes a difference—that was the recurring message from speakers to an overflow audience of rising leaders in the healthcare communication industry as they met in Washington last week for an overview of healthcare policy in the evolving political landscape. “Much of the […]

Read more

Drug Companies Should Be Able to Share Information with Payers

May 2, 2016 – In order to make reasonable coverage decisions about new medicines, payers need access to information from drug companies about those medicines prior to their FDA approval, a practice that currently is restricted under FDA policy, according to a recent blog post in The Catalyst, a Pharmaceutical Research and Manufacturers of America […]

Read more

Industry More Than Ready for FDA Off-label Communications Guidance

Feb. 2, 2016 – The FDA’s recent announcement regarding which new and revised guidance documents it plans to publish in 2016 includes four long-awaited guidance documents by the Office of Prescription Drug Promotion (OPDP). “While the agency has been pondering its options, consumers and health professionals are expecting the industry to move forward and participate […]

Read more

Coalition Arms Industry with Tool Kit to Defend DTC Advertising

Dec. 14, 2015 – With medical marketing being targeted by politicians and the media as one cause of high drug prices, the Coalition for Healthcare Communication is helping its members take action against this claim by providing them with a direct-to-consumer (DTC) Tool Kit that includes talking points and other informational resources. “The public and […]

Read more

NBER: DTC Ads Increase Treatment of the Undertreated and Undiagnosed, Improve Drug Adherence

Dec. 7, 2015 – While direct-to-consumer (DTC) advertising increases the number of drug prescriptions, it also boosts the number of people being treated for commonly undertreated conditions and improves drug adherence, according to a new study released by the National Bureau of Economic Research (NBER). The NBER study, “Prescription Drug Advertising and Drug Utilization: The […]

Read more

AMA Calls for DTC Advertising Ban

Nov. 17, 2015 — The American Medical Association (AMA) announced today that it would support an advertising ban on direct-to-consumer (DTC) advertising in an effort to make prescription drugs more affordable and address member concerns regarding “the negative impact of commercially-driven promotions and the role that marketing costs play in fueling escalating drug prices.” The […]

Read more